Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2019-01-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
第四届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by Guangzhou Yangpu Medical Technology Co., Ltd. It details the decision to terminate a previously planned non-public stock issuance and withdraw the application materials. The text includes meeting details, voting results, and references to related disclosures on a regulatory website. There is no financial data, earnings information, or detailed report content. The document is an official announcement of a board decision, not a full report or financial statement. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1023 characters), and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2019-01-30 Chinese
独立董事关于第四届董事会第十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion regarding the termination of a non-public stock issuance and withdrawal of the application materials. It references regulatory guidelines and company internal rules, and it is a formal statement by independent directors about a board meeting decision. The document is short (856 characters) and does not contain financial statements or detailed financial data. It is not an annual report, audit report, or earnings release. It is also not a general announcement or a report publication announcement. The content fits best with a Board/Management Information filing, as it relates to board decisions and management matters concerning capital raising activities but does not itself announce a financing update or capital change. Therefore, the classification is MANG (Board/Management Information).
2019-01-30 Chinese
第四届监事会第十一次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a resolution passed at a supervisory board meeting of Guangzhou Yangpu Medical Technology Co., Ltd. It details the decision to terminate a previously planned non-public stock issuance and withdraw the application materials with the China Securities Regulatory Commission. The document includes meeting details, voting results, and references to a related announcement on an official disclosure website. It does not contain financial statements, detailed financial analysis, or comprehensive report content. The document is relatively short (957 characters) and serves as an official announcement of a corporate decision rather than a full report or detailed financial disclosure. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to changes in the company's financing activities and capital structure plans.
2019-01-30 Chinese
关于终止非公开发行股票事项并撤回申请材料的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the termination of a previously planned non-public stock issuance and the withdrawal of the related application materials submitted to the China Securities Regulatory Commission. It details the history of the issuance plan, reasons for termination, and the impact on the company. The document is a formal public announcement about a capital raising activity that is being stopped, rather than a financial report or detailed financing update. It does not contain financial statements or detailed financial data but rather informs stakeholders about the cessation of a financing plan and withdrawal of regulatory filings. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2228 characters, which is consistent with an announcement rather than a full report.
2019-01-30 Chinese
关于医疗器械产品延续注册的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the renewal of a medical device registration certificate issued by the National Medical Products Administration. It contains no financial data, no detailed financial performance, no management discussion, no voting results, no legal proceedings, no capital changes, and no executive changes. The document is short (719 characters) and serves as a regulatory announcement about product registration status, which is a compliance-related disclosure. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or others that require financial or management content. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-01-24 Chinese
关于医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding changes to medical device registration certificates issued by the Guangdong Food and Drug Administration. It details specific changes in product packaging specifications for several medical device products. The document is short (1398 characters) and does not contain financial data, management discussion, or regulatory certifications. It is not an annual or interim report, earnings release, or any financial filing. Instead, it is a regulatory announcement about product registration changes, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories.
2019-01-11 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.